MBRS-Based Psychoeducation in Patients With Schizophrenia
The Effect of MBRS-Based Psychoeducation on Anger Management and Functional Recovery in Patients With Schizophrenia
1 other identifier
interventional
75
1 country
1
Brief Summary
This study aimed to determine the effects of mindfulness-based stress reduction training on anger management and functional recovery in patients with schizophrenia. The study will be conducted at a CMHC in Ağrı province between May and August 2021. At the CMHC, community-based mental health services are provided to patients with severe mental disorders (schizophrenia, bipolar disorder) who are in remission as assessed by a psychiatrist. The study is planned to be conducted with patients who meet the study criteria, without using a sample selection method. Patients over the age of 18 registered with CMHC and followed with a diagnosis of schizophrenia were contacted by phone and invited to CMHC. The study was conducted with patients who met the inclusion criteria and agreed to participate (psychoeducational group, mindfulness group, control group). Data will be collected using the Descriptive Characteristics Form, the State and Trait Anger Inventory, and the SILO. The mindfulness group received 16 sessions of MBRS training, and the psychoeducational group received an 8-session psychoeducational program. The control group received no intervention. The study sample size was calculated using the GPower computer program. Power analysis at α=0.05 yielded an effect size of 150, 153 (d=0.8), and the study had 90% power. Therefore, it was calculated that a minimum of 68 patients should be included in the sample.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 30, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 15, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
March 15, 2022
CompletedFirst Submitted
Initial submission to the registry
August 12, 2025
CompletedFirst Posted
Study publicly available on registry
August 19, 2025
CompletedAugust 19, 2025
August 1, 2025
9 months
August 12, 2025
August 12, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Personal Information Form
This form consists of a total of eight questions (age, gender, marital status, education level, duration of illness, income, family history of mental illness, and employment status) developed by the researcher based on literature and includes the sociodemographic characteristics of the patients
up to 1 day
Secondary Outcomes (1)
The State-Trait Anger Scale (STAS)
up to 1 day
Other Outcomes (1)
Functional Recovery Scale in Schizophrenia (FRS)
up to 1 day
Study Arms (24)
Session 1: Preparatory Session
EXPERIMENTAL\*Meeting the patients \*Introducing the content of mindfulness-based stress reduction training \*Emphasizing the importance of regular and timely attendance at training \*Determining training dates \*Sharing individuals' experiences and expectations
Session 2: Mindfulness
EXPERIMENTAL\*What is mindfulness? \*Being aware of daily activities. \*Raisin meditation.
Session 3: Our Perspectives on Ourselves and the World
EXPERIMENTAL\*Breathing meditation. \*Habit Breaker: Watching the Sky.
Session 4: Body Scan *Body scan meditation.
EXPERIMENTAL\*Ten-finger gratitude practice. \*Habit Breaker: Spending some time in nature.
Session 5: Recognizing Schizophrenia
EXPERIMENTAL\*What is schizophrenia? \*What are its symptoms? \*What does treatment involve?
Session 6: Mindful Movement
EXPERIMENTAL\*Mindfulness movement meditation practice \*
Session 7: Mindful Breathing
EXPERIMENTAL\*Breathing meditation
Session 8: Treatment Evaluation
EXPERIMENTAL\*The importance of medication \*Things to consider when using medication \*Side effects of medication \*What is a flare-up in schizophrenia? \*What are the precursor symptoms?
Session 9: Mindful Thinking
EXPERIMENTAL\*Sounds and thoughts meditation \*Cinema activity.
Session 10: Coping with Anger
EXPERIMENTAL\*What is anger? \*What are its symptoms? \*What are the coping methods?
Session 11: Coping with Difficult Emotions
EXPERIMENTAL\*Facing Difficulties meditation
Session 12: Mindful Communication
EXPERIMENTAL\*Communication \& mindful communication \*The importance of communication skills \*Fundamentals of communication, self-language practice \*Ways to prevent communication accidents
Session 13: Different Connections
EXPERIMENTAL\*Breathing meditation. \*Habit Breaker: Thought and Emotional Play.
Session 14: The Joy of the Small Things
EXPERIMENTAL\*Treasure Treasure Meditation \*Habit Breaker: Letter to Self.
Session 15: Dwelling on the Past or Living in the Present?
EXPERIMENTAL\*Friendship-Building Meditation \*Habit Breaker: Random Acts of Kindness.
Session 16: Evaluation *Reinforcing What Has Been Learned.
EXPERIMENTAL\*Evaluating the Program. \*Obtaining Feedback.
Group 2: 2: Recognizing the Illness
ACTIVE COMPARATOR\*What is schizophrenia? \*What are its symptoms? \*What does treatment involve?
Group 2: Session 3: Evaluating Treatment
ACTIVE COMPARATOR\*Considerations regarding medication use \*Side effects of medication use \*Exacerbations in schizophrenia \*Premonitory symptoms.
Group 2: Session 4: *What is anger?
ACTIVE COMPARATOR\*What are the symptoms of anger? \*What are the methods for coping with anger?
Group 2: Session 5: Communication *What is communication?
ACTIVE COMPARATOR\*The importance of communication. \*Fundamentals of communication, self-language practice \*Ways to prevent communication difficulties.
Group 2: Session 6: What is relaxation?
ACTIVE COMPARATORWhat is progressive relaxation. Relaxation CD introduction
Group 2: Session 7: Relaxation
ACTIVE COMPARATORPerforming the relaxation CD with patients
Group 2: Session 8: Evaluation
ACTIVE COMPARATOR\*Reinforcement of what has been learned. \*Evaluation of the program. \*Receiving feedback
Group 2: Session 1: Preparatory Session
ACTIVE COMPARATOR\*Meeting the patients \*Introducing the content of psychoeducation \*Emphasizing the importance of regular and timely attendance at training \*Determining training dates \*Sharing individuals' experiences and expectations
Interventions
\*Meeting the patients \*Introducing the content of mindfulness-based stress reduction training \*Emphasizing the importance of regular and timely attendance at training \*Determining training dates \*Sharing individuals' experiences and expectations
\*What is mindfulness? \*Being aware of daily activities. \*Raisin meditation.
\*Breathing meditation. \*Habit Breaker: Watching the Sky.
\*Ten-finger gratitude practice. \*Habit Breaker: Spending some time in nature.
\*What is schizophrenia? \*What are its symptoms? \*What does treatment involve?
\*Mindfulness movement meditation practice \*
\*The importance of medication \*Things to consider when using medication \*Side effects of medication \*What is a flare-up in schizophrenia? \*What are the precursor symptoms?
\*Sounds and thoughts meditation \*Cinema activity.
\*What is anger? \*What are its symptoms? \*What are the coping methods?
\*Facing Difficulties meditation \*
\*Communication \& mindful communication \*The importance of communication skills \*Fundamentals of communication, self-language practice \*Ways to prevent communication accidents
\*Breathing meditation. \*Habit Breaker: Thought and Emotional Play.
\*Treasure of Pleasure Meditation \*Habit Breaker: Letter to Self.
\*Friendship-Building Meditation \*Habit Breaker: Random Acts of Kindness.
\*Reinforcing What Has Been Learned. \*Evaluating the Program. \*Obtaining Feedback.
\*Meeting Patients \*Introducing the Content of Psychoeducation \*Emphasizing the Importance of Regular and Timely Attendance at Training \*Determining Training Dates \*Sharing Individuals' Experiences and Expectations
\*What is Schizophrenia? \*What are its Symptoms? \*What Does Treatment Include?
\*Things to Consider When Using Medication \*Side Effects of Medication \*Exacerbation of Schizophrenia \*Precursor Symptoms.
\*What are the symptoms of anger? \*What are the methods for coping with anger?
\*What is communication? \*The importance of communication. \*Fundamentals of communication, working on "I" language. \*Ways to prevent communication difficulties.
What is progressive relaxation? Introducing a relaxation CD
Practicing the relaxation CD with patients
\*Reinforcing what has been learned. \*Evaluating the program. \*Obtaining feedback
Eligibility Criteria
You may qualify if:
- Being registered with a CMHC
- Being diagnosed with schizophrenia
- Being between the ages of 18 and 60
- Being willing to participate in the study
- Being open to communication and cooperation
- Being in remission
You may not qualify if:
- Not being open to communication and cooperation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ataturk University Faculty of Nursing
Erzurum, Yakutiye, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mine Cengiz lecturer doctor
Ataturk University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer Physician
Study Record Dates
First Submitted
August 12, 2025
First Posted
August 19, 2025
Study Start
March 30, 2021
Primary Completion
December 15, 2021
Study Completion
March 15, 2022
Last Updated
August 19, 2025
Record last verified: 2025-08